Biomark Diagnostics' CEO is Rashid Ahmed Bux, appointed in Jun 2014, has a tenure of 12.08 years. total yearly compensation is CA$240.00K, comprised of 100% salary and 0% bonuses, including company stock and options. directly owns 2.76% of the company’s shares, worth $1.05M. The average tenure of the management team and the board of directors is 9.1 years and 8.7 years respectively.
Key information
Rashid Ahmed Bux
Chief executive officer
CA$240.0k
Total compensation
CEO salary percentage
100.00%
CEO tenure
12.1yrs
CEO ownership
2.8%
Management average tenure
9.1yrs
Board average tenure
8.7yrs
Recent management updates
Recent updates
CEO Compensation Analysis
How has Rashid Ahmed Bux's remuneration changed compared to Biomark Diagnostics's earnings?
Date
Total Compensation
Salary
Company Earnings
Dec 31 2025
n/a
n/a
-CA$2m
Sep 30 2025
n/a
n/a
-CA$2m
Jun 30 2025
n/a
n/a
-CA$2m
Mar 31 2025
CA$240k
CA$240k
-CA$2m
Dec 31 2024
n/a
n/a
-CA$2m
Sep 30 2024
n/a
n/a
-CA$2m
Jun 30 2024
n/a
n/a
-CA$2m
Mar 31 2024
CA$240k
CA$240k
-CA$1m
Dec 31 2023
n/a
n/a
-CA$2m
Sep 30 2023
n/a
n/a
-CA$2m
Jun 30 2023
n/a
n/a
-CA$2m
Mar 31 2023
CA$240k
CA$240k
-CA$2m
Dec 31 2022
n/a
n/a
-CA$2m
Sep 30 2022
n/a
n/a
-CA$2m
Jun 30 2022
n/a
n/a
-CA$2m
Mar 31 2022
CA$240k
CA$240k
-CA$1m
Dec 31 2021
n/a
n/a
-CA$1m
Sep 30 2021
n/a
n/a
-CA$1m
Jun 30 2021
n/a
n/a
-CA$1m
Mar 31 2021
CA$240k
CA$240k
-CA$1m
Dec 31 2020
n/a
n/a
-CA$796k
Sep 30 2020
n/a
n/a
-CA$1m
Jun 30 2020
n/a
n/a
-CA$1m
Mar 31 2020
CA$240k
CA$240k
-CA$1m
Compensation vs Market: Rashid Ahmed's total compensation ($USD168.99K) is below average for companies of similar size in the US market ($USD659.85K).
Compensation vs Earnings: Rashid Ahmed's compensation has been consistent with company performance over the past year.
CEO
Rashid Ahmed Bux
12.1yrs
Tenure
CA$240,000
Compensation
Mr. Rashid Ahmed Maula Bux, B.Sc., MBA, is the Founder of BioMark Technologies Inc., a bio pharm business, which has achieved Phase III status and has been its Chief Executive Officer since June 19, 2014....
Leadership Team
Name
Position
Tenure
Compensation
Ownership
Rashid Ahmed Bux
Founder
12.1yrs
CA$240.00k
2.76% $ 1.1m
Guoyu Huang
Chief Financial Officer
9.1yrs
CA$100.20k
4.7% $ 1.8m
Brian Cheng
Chief Technical Officer & Independent Director
no data
no data
no data
Jeff Haince
GM & Chief Scientific Officer
5.3yrs
no data
no data
9.1yrs
Average Tenure
Experienced Management: BMKD.F's management team is seasoned and experienced (9.1 years average tenure).
Board Members
Name
Position
Tenure
Compensation
Ownership
Rashid Ahmed Bux
Founder
12.1yrs
CA$240.00k
2.76% $ 1.1m
Brian Cheng
Chief Technical Officer & Independent Director
11.8yrs
no data
no data
Alfred Berkeley
Member of Advisory Board
5.5yrs
no data
no data
James Lavender
Director
less than a year
no data
4.92% $ 1.9m
Bill Good
Member of Media Advisory Board
no data
no data
no data
Bramhanand Ramjiawan
Independent Director
11.8yrs
no data
no data
Theresa Peterson
Member of Advisory Board
2.4yrs
no data
no data
8.7yrs
Average Tenure
Experienced Board: BMKD.F's board of directors are considered experienced (8.7 years average tenure).
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/07/05 10:56
End of Day Share Price
2026/07/02 00:00
Earnings
2025/12/31
Annual Earnings
2025/03/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Biomark Diagnostics Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.